Search results
Immunotherapy for Cancer: What Are My Options?
Verywell Health via Yahoo News· 9 months agoImmunotherapy is a relatively new approach to cancer treatment. It improves the body's immune system's ability to find and fight cancer. Since 2010,...
'Extraordinary' study results offer new hope for advanced lung cancer patients being treated with...
USA TODAY via Yahoo News· 2 years agoPatients with advanced lung cancer had a better chance at survival when their treatment combined...
Advanced Esophageal Cancer and Immunotherapy
Verywell Health via Yahoo News· 9 months agoA Newer Treatment OptionMedically reviewed by Gagandeep Brar, MD Immunotherapy for esophageal cancer is a newer treatment approach shown to improve the...
Merck's Keytruda combo gets FDA nod for expanded use in cervical cancer
Reuters via Yahoo News· 4 months agoThe Keytruda combination was approved for patients with cervical cancer who had not previously...
Immunotherapy drugs helps in fight against cancer, explains Savannah doctor
Savannah Morning News via Yahoo News· 7 months agoImmunotherapy is a recent addition to the arsenal of weapons used against cancer. A Savannah area...
Women with advanced breast cancer get new immunotherapy on the NHS
Press Association News via AOL· 2 years agoAround 100 women a year with advanced breast cancer will be able to try a new type of immunotherapy...
Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return
Reuters via Yahoo Finance· 1 year agoAn experimental mRNA cancer vaccine developed by Moderna Inc and Merck & Co cut the risk of death or...
Merck Gambled With Keytruda In 2011 — How That Jump Is Still Paying Off Today
Investor's Business Daily· 2 years agoA gamble Merck made more than 10 years ago could pay off again for the pharmaceutical giant's stock...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via AOL· 3 weeks agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Merck keeps deal focus with Keytruda patent cliff on horizon
BioPharma Dive via Yahoo Finance· 4 months agoMerck & Co. plans to continue seeking out multibillion-dollar biotechnology deals to supplement its...